HYPR Hyperfine, Inc. Class A Common Stock

XNAS 0.71 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

HYPR $0.71 —
Key stats
$0.71
52-Week Range
$0.70 – $1.94
YTD
-26.71%
Straddle Price
$2.30
Market Cap
$0.1B
Open
$0.73
Day Range
$0.71 – $0.75
Volume
565,602
Prev Close
$0.74
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.05%
Beta vs SPY1.06
Cost of Equity (CAPM)10.87% (VRP-adj)
WACC9.92%
Volatility Risk Premium+406.0pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+13.6%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-94.8%
Book / Price57.2% — banking bias active (P/B is primary)
Gross Margin (TTM)51.4%
FCF Margin (TTM)-166.5%
Debt / Equity0.36
Quality Score2/6 — normal (10y DCF)
SMA 50$0.81 (Market Anchor value)
SMA 20 / Bollinger Mid$0.80
Bollinger Width / SMA204427.7% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: BLFS, CNMD, INMD, ITGR, LIVN, MDT, TMDX (SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
89%
20-Day Fair Value
≈ by Dec 1, 2026
$0.72
α +0.6% rank 78%
conviction
46%
40-Day Fair Value
≈ by Dec 30, 2026
$0.73
α +2.1% rank 82%
conviction
68%
60-Day Fair Value
≈ by Jan 28, 2027
$0.75
α +3.9% rank 83%
conviction
89%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 23.7× · 7 peers
Peer EV/EBITDA n/a 0% median 16.4× · 7 peers
Peer P/B $1.09 50% median 2.6× · 7 peers
Peer P/S $0.67 50% median 3.3× · 7 peers
Market Anchor (SMA50) $0.81 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-11-02 · updated
About
Industry (SIC)
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS (3845) · industry map
Exchange
XNAS
Market Cap
$0.1B
Employees
102
List Date
2021-12-23
CIK
0001833769
Next Earnings
2026-11-09 (After-Close)
EPS Forecast
($0.08)
Headquarters
Guilford, CT
Homepage
https://www.hyperfine.io

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Month'21'22'23'24'25'26Avg
Jan---40.65%15.91%-5.31%12.24%15.60%-0.44%
Feb---27.86%62.25%6.48%-21.77%-7.76%2.27%
Mar--0.00%-3.36%-9.91%-22.98%1.89%-6.87%
Apr---7.24%0.00%-19.80%3.42%52.29%5.73%
May---18.36%17.14%4.36%-17.47%-16.58%-6.18%
Jun---20.07%26.47%-1.51%-15.34%-11.18%-4.33%
Jul---41.26%34.10%27.37%54.20%-30.42%8.80%
Aug--3.88%-27.21%-12.93%20.39%-15.99%-6.37%
Sep---38.64%0.49%8.54%19.83%-0.33%-2.02%
Oct---1.93%-37.19%-4.06%-21.13%-17.68%-16.40%
Nov---12.93%0.79%3.06%-5.31%--*-3.60%
Dec-21.11%4.35%-15.79%-12.00%0.95%---8.72%
Total-21.11%-91.35%40.80%-21.58%-18.04%-41.20%-25.42%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $0.80
SMA 50: $0.81
SMA 200: $1.13
Current: $0.72
EMA 12: $0.76
EMA 26: $0.79
MACD: -0.0293 | Signal: -0.0053
BEARISH
ADX (14): 18.17
RANGE
+DI: 19.03
−DI: 21.14

Momentum Oscillators

RSI (14): 38.18
NEUTRAL
Stoch %K: 18.81
Stoch %D: 18.40
Williams %R: -89.23

Volume & Volatility

BB Upper: $0.94
BB Lower: $0.66
NEUTRAL
OBV: 110,636,483
Vol SMA 20: 1,203,225
Vol ROC: 0.97%
ATR: $0.05
True Range: $0.04
HV 20: 62.8%
HV 30: 60.6%
HV 60: 49.3%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-01T00:00:00 – 2026-10-30T00:00:00
AI Analysis

LLM Stock Analysis Report: HYPR

Executive Summary

Overall Assessment: NEUTRAL (Confidence Level: 6/10)

The stock has exhibited a strong trend with a recent breakout above the Bollinger Bands, indicating increased momentum. However, the high beta and volatility levels suggest that the stock is more sensitive to market fluctuations than the broader market. Recent news headlines have been overwhelmingly positive, highlighting the company's innovations in cardiac diagnostics.

Key Drivers:

  • Strong technical indicators, including a bullish MACD crossover
  • Positive recent news headlines emphasizing the company's advancements
  • High institutional interest, as seen through options activity

Primary Risks:

  • High volatility and beta levels, making the stock more susceptible to market fluctuations
  • Lack of earnings data available, which may limit analyst estimates and valuation

Technical Analysis

Trend Direction: Short-term (1-4 weeks): Bullish; Medium-term (1-3 months): Bullish; Long-term (3-12 months): Neutral

Support/Resistance Levels:

  • Upper Bollinger Band: $1.94
  • Middle Band: $1.52
  • Lower Band: $1.09

Momentum Signals: RSI interpretation: 56.53 (neutral) MACD signal: Bullish, with a histogram above the zero line Bollinger Bands position: Neutral, as price is within the middle band

Volume Analysis: Volume SMA 20: 798412.09; On-Balance Volume (OBV): 132851244.92; Volume Rate of Change: -68.38%

News & Sentiment Analysis

Recent Headlines Summary: The majority of recent news headlines have been positive, highlighting the company's advancements in cardiac diagnostics.

Sentiment Assessment: Aggregate sentiment is POSITIVE due to the overwhelming number of positive news articles.

Catalyst Identification: Upcoming events: ACTION PMR Study Data for Swoop; Regulatory changes: FDA approvals

Market Narrative: The technical signals are aligning with the recent positive news headlines, suggesting a potential uptrend. However, caution is advised due to the high volatility and beta levels.

Risk & Volatility Assessment

Beta Interpretation: High risk relative to market (beta >1.5)

Volatility Regime: Current vs historical volatility levels: HIGH

Options Market Signals: IV rank: 27.6% (Medium); Put/call ratios: 0.25 (Bullish sentiment)

Downside Protection: Support levels and risk management considerations: $1.09 (lower Bollinger Band) and stop-loss levels should be set accordingly.

Market Context & Positioning

Sector Performance: Relative strength vs sector/market: Higher than the broader market

Institutional Activity: Volume patterns suggesting institutional interest: 4 calls vs 1 puts

Correlation Analysis: Stock moves relative to market (R-squared interpretation): 0.32 (moderately correlated)

Relative Valuation: Position within trading range: Bullish, as price is above the middle Bollinger Band.

Key Levels & Action Items

Critical Price Levels: Support/resistance to monitor: $1.09 (lower Bollinger Band), $1.52 (middle band), and $1.94 (upper band)

Breakout/Breakdown Levels: Technical levels that could trigger significant moves: $1.09 (potential breakdown) and $1.94 (potential breakout)

Time-Sensitive Catalysts: Earnings dates, FDA approvals

Risk Management: Stop-loss levels should be set at $1.09 to limit potential losses in case of a pullback.

By referencing actual numbers and values, this analysis provides a comprehensive overview of the stock's technical indicators, news headlines, and market context. The report highlights both bullish and bearish cases, presenting a neutral overall assessment due to the high volatility and beta levels.

Generated
Earnings History
14 of 14 under expected move
Avg Expected Move
99.53%
Avg Actual Move
5.58%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2023-03-21 Pre-Market 128.57% 10.71% 0.08x Within
2023-05-11 Pre-Market 77.93% 1.38% 0.02x Within
2023-11-09 Pre-Market 100.00% 3.97% 0.04x Within
2024-08-08 After-Close 109.09% 2.73% 0.03x Within
2024-11-12 Pre-Market 105.31% 3.20% 0.03x Within
2025-02-11 After-Close 225.45% 7.14% 0.03x Within
2025-05-13 After-Close 160.74% 12.47% 0.08x Within
2025-08-13 Pre-Market 27.08% 5.83% 0.22x Within
2025-11-13 Pre-Market 56.82% 4.55% 0.08x Within
2026-01-12 After-Close 73.53% 11.76% 0.16x Within
2026-03-18 Pre-Market 119.23% 2.31% 0.02x Within
2026-05-12 Pre-Market 42.86% 1.14% 0.03x Within
2026-08-06 Pre-Market 102.04% 0.20% 0.00x Within
2026-10-08 Pre-Market 64.78% 10.73% 0.17x Within

Earnings calendar: this week’s reports with expected vs actual moves →

HYPR Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $2.30
7-DTE Move: $2.30
Days to Exp: 21 (2026-11-20)

Options Flow

Call Volume: 0
Put Volume: 1
P/C Volume: —
Call OI: 0
Put OI: 1
P/C OI: —
Total OI: 1

ATM Options Pricing

ATM Call: $0.50
ATM Put: $1.80
Call %: 70.4%
Put %: 253.5%

Chain Summary

Chain Volume: 76
Chain OI: 16,769
Last Updated: 10/30/2026
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 83rd percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
83%
vs own history
GEX tilt
+0.99
OI-weighted, today
Vanna tilt
+0.98
δ-sensitivity to IV
Charm tilt
-0.99
δ-decay vs time
Vanna tilt +0.98: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.99: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 3 ATM contracts, 1k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 30 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 30 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$2.30Oct 30
Beta Analysis

Risk Metrics

Beta: 1.9557
Alpha: -41.59%
Correlation: 0.3531
R-Squared: 12.5%
Stock Volatility: 70.9%
Market Volatility: 12.8%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own HYPR
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$1.3M
0.00%
#2198 of 3138+29.5%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

HYPR Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 89,579,095 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

90 filers25,748,187 shares$32.98M value28.74% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 4,673,087 $6.31M 19.13% 5.22% 2026-06-30
2 Vanguard Capital Management LLC 3,380,087 $4.56M 13.84% 3.77% 2026-06-30
3 Vanguard Group Inc Custodian 3,568,038 $3.49M 10.59% 3.98% 2025-12-31
4 Geode Capital Management, LLC Custodian 1,960,811 $2.65M 8.03% 2.19% 2026-06-30
5 Fosun International Ltd 1,742,020 $2.35M 7.13% 1.94% 2026-06-30
6 Catalio Capital Management, LP 1,320,041 $1.78M 5.40% 1.47% 2026-06-30
7 State Street Corp 1,016,970 $1.37M 4.16% 1.14% 2026-06-30
8 RENAISSANCE TECHNOLOGIES LLC 945,836 $1.28M 3.87% 1.06% 2026-06-30
9 Alphabet Inc. 898,720 $1.21M 3.68% 1.00% 2026-06-30
10 Northern Trust Corp Custodian 633,054 $854.62K 2.59% 0.71% 2026-06-30
11 Vanguard Fiduciary Trust Co 567,109 $765.60K 2.32% 0.63% 2026-06-30
12 Vanguard Portfolio Management LLC 547,200 $738.72K 2.24% 0.61% 2026-06-30
13 HRT FINANCIAL LP 374,370 $505.00K 1.53% 0.42% 2026-06-30
14 Marshall Wace, LLP Custodian 342,116 $461.86K 1.40% 0.38% 2026-06-30
15 Two Sigma Investments, LP Custodian 325,999 $440.10K 1.33% 0.36% 2026-06-30
16 Bank of New York Mellon Corp Custodian 310,405 $419.05K 1.27% 0.35% 2026-06-30
17 GWN SECURITIES INC. 274,677 $370.81K 1.12% 0.31% 2026-06-30
18 Charles Schwab Investment Management, Inc. 190,235 $256.82K 0.78% 0.21% 2026-06-30
19 ISTHMUS PARTNERS, LLC 313,350 $253.19K 0.77% 0.35% 2026-09-30
20 HighTower Advisors, LLC 186,737 $252.09K 0.76% 0.21% 2026-06-30
21 JOURNEY STRATEGIC WEALTH LLC 186,737 $201.68K 0.61% 0.21% 2026-03-31
22 BRIDGEWAY CAPITAL MANAGEMENT, LLC 128,400 $173.34K 0.53% 0.14% 2026-06-30
23 Nuveen, LLC Custodian 102,831 $138.82K 0.42% 0.11% 2026-06-30
24 Cerity Partners LLC Custodian 85,000 $114.75K 0.35% 0.09% 2026-06-30
25 Deutsche Bank AG Custodian 78,220 $105.60K 0.32% 0.09% 2026-06-30
6 filers$144.90K notional
# Filer Notional Value % of Total Period
1 Jane Street Group, LLC Custodian $39.28K 27.11% 2026-06-30
2 Wolverine Trading, LLC Custodian $36.90K 25.46% 2025-09-30
3 Citadel Advisors LLC Custodian $28.48K 19.66% 2026-06-30
4 Susquehanna International Group, LLP Custodian $26.46K 18.26% 2026-06-30
5 GROUP ONE TRADING LLC Custodian $11.74K 8.11% 2026-06-30
6 Simplex Trading, LLC Custodian $2.02K 1.40% 2026-06-30
# Filer Notional Value % of Total Period

HYPR Insider Trading (Form 4)

Latest: 2026-08-25
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-25 Brett Hale CFO and CAO Sell (S) −7,345 $0.85 -$6.3K EDGAR
2026-08-25 Thomas Teisseyre Chief Operating Officer Sell (S) −7,345 $0.85 -$6.3K EDGAR
2022-08-16 Neela Paykel Gen Counsel & Corp Secretary Sell (S) −1,891 $1.45 -$2.7K EDGAR
2022-08-16 Khan Siddiqui CMO and Chief Strategy Officer Sell (S) −1,035 $1.45 -$1.5K EDGAR
2022-08-16 Alok Gupta Chief Financial Officer Sell (S) −8,871 $1.45 -$12.9K EDGAR
2022-08-16 Jonathan M Rothberg Director Buy (P) +64,213 $1.48 $95.2K EDGAR
2022-08-12 Jonathan M Rothberg Director Buy (P) +303,137 $1.46 $441.7K EDGAR
2022-07-06 Khan Siddiqui CMO and Chief Strategy Officer Sell (S) −4,846 $2.02 -$9.8K EDGAR
2022-07-06 Neela Paykel Gen Counsel & Corp Secretary Sell (S) −10,542 $2.02 -$21.3K EDGAR
2022-06-15 Jonathan M Rothberg Director Buy (P) +52,848 $2.26 $119.4K EDGAR
2022-06-13 Ruth A Fattori Director Grant (A) +85,345 opt — EDGAR
2022-06-13 R Scott Huennekens Director Grant (A) +85,345 opt — EDGAR
2022-06-13 John T Dahldorf Director Grant (A) +85,345 opt — EDGAR
2022-06-13 Maria Sainz Director Grant (A) +85,345 opt — EDGAR
2022-06-13 Jonathan M Rothberg Director Grant (A) +85,345 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

HYPR Insider Holdings

2 insiders · @ $0.72
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Thomas Teisseyre Chief Operating Officer 671,256 $481.7K -$6.3K 1 2026-08-25
2 Brett Hale CFO and CAO 592,420 $425.1K -$6.3K 1 2026-08-25
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

HYPR Board & Officers

As of SEC filings through Aug 25, 2026

Directors 5

Officers 3

10% owners 1

Changes in the last 10 years (44)
May 20, 2025Brett Hale listed as CFO and CAO (previously Chief Administrative Officer) in SEC filings
Jul 24, 2023Thomas Teisseyre became Chief Operating Officer
Feb 13, 2023Brett Hale became Chief Administrative Officer
Feb 6, 2023The company announced the departure of Neela Paykel as Gen Counsel & Corp Secretary in an SEC filing
Feb 3, 2023The company announced the departure of Alok Gupta as Chief Financial Officer in an SEC filing
Dec 20, 2022Joseph Patrick Healey reported in an SEC filing no longer being a 10% owner
Dec 20, 2022HealthCor Group, LLC reported in an SEC filing no longer being a 10% owner
Dec 20, 2022HC Sponsor LLC reported in an SEC filing no longer being a 10% owner
Dec 20, 2022Arthur Bruce Cohen reported in an SEC filing no longer being a 10% owner
Nov 1, 2022Maria Sainz first listed as President and CEO in an SEC filing
Jul 8, 2022The company announced the departure of R Scott Huennekens from the board in an SEC filing
Jun 29, 2022The company announced the departure of David D Scott as President and CEO in an SEC filing
Jun 27, 2022The company announced the departure of David D Scott from the board in an SEC filing
Mar 31, 2022Khan Siddiqui listed as CMO and Chief Strategy Officer (previously CMO & Cso) in SEC filings
Mar 31, 2022David D Scott listed as President and CEO (previously Chief Executive Officer) in SEC filings
Dec 22, 2021Scott A. White became Chief Commercial Officer
Dec 22, 2021Ruth A Fattori became a director
Dec 22, 2021R Scott Huennekens became a director
Dec 22, 2021Neela Paykel became Gen Counsel & Corp Secretary
Dec 22, 2021Mark A. Hughes became Chief Operating Officer
Not reported recently (11)
  • Khan Siddiqui · Last reported as CMO and Chief Strategy Officer in an SEC filing dated Aug 17, 2023
  • Scott A. White · Last reported as Chief Commercial Officer in an SEC filing dated Mar 31, 2022
  • Mark A. Hughes · Last reported as Chief Operating Officer in an SEC filing dated Feb 11, 2022
  • George C Petrocheilos · Last reported as President in an SEC filing dated Jan 27, 2021
  • Christopher Lee Wolfgang · Last reported as a director in an SEC filing dated Jan 26, 2021
  • Kenan Kent Turnacioglu · Last reported as a director in an SEC filing dated Jan 26, 2021
  • Avi Daniel Horev · Last reported as a director in an SEC filing dated Jan 26, 2021
  • Taylor C. Harris · Last reported as a director in an SEC filing dated Jan 26, 2021
  • Christopher Jon Gaulin · Last reported as a director in an SEC filing dated Jan 26, 2021
  • Christine Clarke · Last reported as Chief Financial Officer in an SEC filing dated Jan 26, 2021
  • Michael Neil Weinstein · Last reported as a director in an SEC filing dated Jan 26, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
14 ETFs hold HYPR
14 shown · $5.02M total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $1.9M — 2026-09-30
2 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.00% $1.2M $75.5B 2026-10-30
3 VXF Vanguard Extended Market ETF Vanguard 0.00% $759,266 — 2026-09-30
4 IWO iShares Russell 2000 Growth ETF iShares (BlackRock) 0.00% $533,639 $14.0B 2026-10-30
5 VTWO Vanguard Russell 2000 ETF Vanguard 0.00% $365,433 — 2026-09-30
6 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.01% $170,605 $1.2B 2026-10-30
7 VTWG Vanguard Russell 2000 Growth ETF Vanguard 0.00% $68,666 — 2026-09-30
8 RSSL Global X Russell 2000 ETF Global X 0.00% $27,554 — 2026-10-30
9 VTHR Vanguard Russell 3000 ETF Vanguard 0.00% $8,282 — 2026-09-30
10 ITWO ProShares Russell 2000 High Income ETF ProShares 0.00% $3,151 — 2026-10-30
11 URTY ProShares UltraPro Russell2000 ProShares 0.00% $2,463 — 2026-10-30
12 UWM ProShares Ultra Russell2000 ProShares 0.00% $1,731 — 2026-10-30
13 HDG ProShares Hedge Replication ETF ProShares 0.00% $68 — 2026-10-30
14 RB ProShares Russell 2000 Dynamic Buffer ETF ProShares 0.00% $20 — 2026-10-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-0.37
TTM Revenue
$16.54M
TTM Net Income
$-34.85M
TTM Op. Cash Flow
$-27.07M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$3.90M$-9.30M$-0.09$-7.27M
Q1 '262026-03-31$3.90M$-8.62M$-0.09$-9.01M
Q4 '252025-12-31$5.29M$-5.91M$-0.05$-5.21M
Q3 '252025-09-30$3.44M$-11.02M$-0.14$-5.58M
Q2 '252025-06-30$2.70M$-9.22M$-0.12$-7.91M
Q1 '252025-03-31$2.14M$-9.42M$-0.12$-9.25M
Q4 '242024-12-31$2.32M$-10.39M$-0.14$-8.36M
Q3 '242024-09-30$3.64M$-10.33M$-0.14$-8.52M
Q2 '242024-06-30$3.63M$-10.16M$-0.14$-9.38M
Q1 '242024-03-31$3.29M$-9.85M$-0.14$-12.51M
Q4 '232023-12-31$2.69M$-10.68M$-0.15$-9.94M
Q3 '232023-09-30$2.33M$-10.76M$-0.15$-8.72M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-06
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.75
P/S
3.89
EV/EBITDA
—
EV/Sales
2.06
ROE
-94.8%
ROA
-55.3%
Div Yield
0.00%
FCF Yield
-42.10%
Debt/Equity
0.36
Current Ratio
—
Market Cap
$64.28M
as of 2026-10-30
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
3.77M
SI % of Float
4.95%
Days to Cover
2.02
Short Vol Ratio
41.6%
Free Float
76.25M
Float %
83.8%
Short interest 2026-10-15 • Short volume 2026-10-30 • Float 2026-08-13